Immunity to malaria and infectious diseases during pregnancy
Immunological and physiological changes during pregnancy render pregnant women to be more susceptible to, and more severely affected by infectious diseases. How the maternally acquired immune response changes throughout pregnancy in both the presence and absence of pathogens remains unknown.
Objective
Using malaria (the most important parasitic pathogen in pregnancy) as a model, we aim to address fundamental questions on the modulation of antibody acquisition and maintenance during pregnancy and assess the ability to boost antibody responses upon re-exposure to pathogens in pregnant women.
Timeline
2019–2024.
Community impact
This research will improve our understanding of the development and maintenance of immunity against infectious diseases in pregnant women and the susceptibility of pregnant women to infectious pathogens.
The findings will enable us to develop epidemiological frameworks for further comprehensive immunological studies of malaria and other pathogens in pregnant and non-pregnant individuals, assess the usefulness of sero-epidemiological tools for population sentinel surveillance in this high-risk group, and inform vaccine development of candidate malaria vaccines for the use in pregnant women.
Partners
Funding partners
National Health and Medical Research Council
Collaborators
- Shoklo Malaria Research Unit, Thailand
- Mahidol Oxford Research Unit, Thailand
- The University of Melbourne, Australia
Project contacts
Professor Freya J.I. Fowkes
Deputy Program Director, Women’s, Children’s and Adolescents’ Health; Head, Malaria and Infectious Disease Epidemiology
Project team
Professor James Beeson
Deputy Director, Research Strategy; Head, Malaria Immunity and Vaccines Group; Adjunct Professor, Monash University
Professor Freya J.I. Fowkes
Deputy Program Director, Women’s, Children’s and Adolescents’ Health; Head, Malaria and Infectious Disease Epidemiology
